<PAGE>




                                    FORM 10-Q
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

(Mark One)
[ X ]    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

                  For the quarterly period ended June 30, 1997
                                       or
[   ]    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

For the transition period from ___________________ to ___________________

Commission file Number: 0-15196

                             The Centris Group, Inc.
                             -----------------------
             (Exact name of Registrant as specified in its charter)

          DELAWARE                                            33-0097221
          --------                                            ----------
(State or other jurisdiction of                             (I.R.S. Employer
 incorporation or organization)                           Identification Number)

             650 Town Center Drive, Suite 1600, Costa Mesa, CA 92626
             -------------------------------------------------------
            (Address of principal executive offices)      (Zip code)

                                 (714) 549-1600
                                 --------------
              (Registrant's telephone number, including area code)

                            US FACILITIES CORPORATION
                            -------------------------
(Former name, former address and former fiscal year, if changed since last
 report.)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  Registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

YES    X                                       NO
   ---------                                     -------

Number of shares outstanding of each class of the Registrant's Common Stock as
of August 7, 1997:

Common Stock, par value $.01 per share:  5,987,898
Common Stock Purchase Rights:            5,987,898


<PAGE>


                                      INDEX


Part I         FINANCIAL INFORMATION

   Item 1.  FINANCIAL INFORMATION
                  Condensed Consolidated Financial Statements:

            Balance Sheets as of June 30, 1997 and
                  December 31, 1996...........................................3

            Income Statements for the Quarters  and Six Months Ended
                  June 30, 1997 and 1996......................................4

            Statements of Cash Flows for the Six Months Ended
                  June 30, 1997 and 1996......................................5

            Notes to Condensed Consolidated Financial Statements..............6

   Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS
            OF FINANCIAL CONDITION AND RESULTS OF
            OPERATIONS........................................................7

Part II         OTHER INFORMATION

   Item 4.  SUBMISSION OF MATTERS TO A VOTE
            OF SECURITY HOLDERS..............................................13


   Item 6.      EXHIBITS and REPORTS ON FORM 8-K.............................14

SIGNATURES...................................................................16

                                       2
<PAGE>


                          PART I FINANCIAL INFORMATION

     Item 1. FINANCIAL INFORMATION
             Condensed Consolidated Financial Statements:

<TABLE>
                             The Centris Group, Inc.
                      Condensed Consolidated Balance Sheets
                             (Dollars in Thousands)
<CAPTION>
ASSETS
                                                               June 30, 1997               December 31,1996
                                                               -------------               ----------------
   <S>                                                           <C>                            <C>

   Investments, at market (amortized cost $190,209 at
   June 30, 1997, $185,472 at December 31, 1996)                 $   202,455                    $   194,352
   Cash and invested cash                                              9,302                         11,132
   Restricted cash and short term investments                         25,976                         23,771
   Accrued investment income                                           2,948                          2,653
   Receivables:
        Reinsurance losses and reserves                               26,868                         23,975
        Premiums                                                      22,363                         16,841
   Prepaid reinsurance premiums                                        7,624                          6,495
   Deferred policy acquisition costs                                   4,440                          3,644
   Other assets                                                       11,004                          5,880
                                                                  ----------                    -----------
     Total assets                                                 $  312,980                    $   288,743
                                                                  ==========                    ===========

LIABILITIES AND STOCKHOLDERS' EQUITY

Liabilities
  Insurance liabilities:
     Amounts due insurance companies                             $    29,206                    $    27,148
     Losses and loss adjustment expenses                             106,684                         94,669
     Unearned premiums                                                28,145                         22,936
  Note payable                                                        33,750                         35,000
  Accounts payable and accrued expenses                                3,879                          6,626
                                                                 -----------                    -----------                 

     Total liabilities                                               201,664                        186,379

Stockholders' Equity                                                 111,316                        102,364
                                                                 -----------                    -----------

     Total liabilities and stockholders' equity                  $   312,980                    $   288,743
                                                                 ===========                    ===========
</TABLE>

See accompanying notes to condensed consolidated financial statements.


                                       3
<PAGE>


<TABLE>
                             The Centris Group, Inc.
                    Condensed Consolidated Income Statements
<CAPTION>
                  (Dollars in Thousands, except per share data)


                                                              Quarter Ended              Six Months Ended
                                                                 June 30                      June 30
                                                                 -------                      -------
                                                           1997          1996           1997          1996
                                                           ----          ----           ----          ----
    <S>                                                <C>           <C>            <C>           <C> 
    Revenues:
       Premiums earned                                 $  38,103     $  29,707      $  77,386     $  58,859
       Commissions and fees                                8,140         6,305         16,182        12,894
       Net investment income                               2,712         2,526          5,403         4,968
       Realized investment gains                              78           (9)            255           726
                                                       ---------     ---------      ---------     ---------

         Total revenues                                   49,033        38,529         99,226        77,447
                                                       ---------     ---------      ---------     ---------

    Operating Expenses:

       Losses and loss adjustment expenses
         incurred                                         27,526        20,852         55,522        41,694
       Policy acquisition expenses                        11,083         8,818         22,992        17,692
       General and administrative expenses                 4,447         3,379          8,901         6,924
       Interest                                              614           699          1,228         1,379
                                                       ---------     ---------      ---------     ---------
         Total operating expenses                         43,670        33,748         88,643        67,689
                                                       ---------     ---------      ---------     ---------

    Income before income taxes                             5,363         4,781         10,583         9,758

         Income tax expense                                1,615         1,196          3,175         2,365
                                                       ---------     ---------      ---------     ---------

    Net income                                         $   3,748     $   3,585     $    7,408     $   7,393
                                                       =========     =========     ==========     =========

    Net income per common and common equivalent
    share                                              $    0.62     $    0.60     $     1.22     $    1.24
                                                       =========     =========     ==========     =========
                                                       
    Weighted average number of common and common
    equivalent shares outstanding during period
                                                           6,080         5,972          6,083         5,971
                                                       =========     =========     ==========     =========

</TABLE>

   See accompanying notes to condensed consolidated financial statements.

                                       4

<PAGE>


<TABLE>
                             The Centris Group, Inc.
                 Condensed Consolidated Statements of Cash Flows

<CAPTION>
                             (Dollars in Thousands)


                                                             Six Months Ended June 30,
                                                              1997               1996
                                                              ----               ----
<S>                                                     <C>                   <C>

Cash provided by operating activities                   $     4,659           $    15,432
                                                        -----------           -----------

Cash flows from investing activities:

    Purchases of fixed maturity investments                 (16,983)              (18,642)
    Purchases of equity securities                             (627)               (1,571)
    Proceeds from sales of investment securities             14,310                13,923
    Net purchases of short term
    investments                                                (937)               (5,622)
    Purchases of property and equipment                        (447)                 (972)
                                                        ------------          ------------

Cash used in investing activities                            (4,684)              (12,884)
                                                        ------------          ------------

Cash flows from financing activities:
    Payment on note payable                                  (1,250)                   --
    Dividends paid                                             (716)                 (702)
    Exercise of stock options                                   161                 1,009
                                                        ------------          ------------

Cash (used in) provided by financing activities              (1,805)                  307
                                                        ------------          ------------

Net (decrease) increase in cash and invested cash            (1,830)                2,855

Cash and invested cash at beginning of period                11,132                 8,165
                                                        ------------          ------------

Cash and invested cash at end of period                 $     9,302            $   11,020
                                                        ============           ===========

Supplemental disclosure of cash flow information:

Interest paid                                           $     1,160            $      662
                                                        ============           ===========

Income taxes paid, net                                  $     2,580           $     2,242
                                                        ============          ============
</TABLE>

See accompanying notes to condensed consolidated financial statements.

                                       5

<PAGE>


                             The Centris Group, Inc.
              Notes to Condensed Consolidated Financial Statements

1.   General

The accompanying unaudited condensed consolidated financial statements have been
prepared in accordance with generally  accepted  accounting  principles and with
the  instructions  to Form 10-Q.  Accordingly,  they do not  include  all of the
information and footnotes required by generally accepted  accounting  principles
for complete financial statements. In the opinion of management, all adjustments
(consisting only of normal recurring accruals)  considered  necessary for a fair
presentation  have been  included.  The results of operations for the six months
ended June 30,1997 are not necessarily  indicative of the results to be expected
for the full year. For further information,  refer to the consolidated financial
statements and footnotes thereto for the year ended December 31,1996 included in
the 1996 Annual Report to  Stockholders  of The Centris  Group,  Inc.,  formerly
known as US Facilities Corporation, (the "Company").

2.    Other

SFAS No. 128,  "Earnings  per Share" and SFAS No. 129,  "Disclosure  of
Information about Capital Structure" will be adopted by the Company for the year
ended  December 31, 1997.  Adoption of these  pronouncements  is not expected to
have a material effect on the financial statements or the related disclosures of
the Company.

3.    Acquisition

Effective  January 1,1997,  the Company  acquired the medical stop loss
business of Global Excess Re, Inc. ("Global") in a transaction  accounted for as
a  purchase.  The  purchase  transaction  was  not  material  to  the  financial
statements  of the  Company.  The  results  of  operations  of Global  since the
acquisition  date  are  included  in  the  accompanying  condensed  consolidated
financial statements.


                                       6
<PAGE>


Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
         CONDITION AND RESULTS OF OPERATIONS

Results Of Operations
---------------------

Consolidated  revenues of The Centris Group, Inc., formerly known as US
Facilities  Corporation,  (the  "Company")  increased 27% to $49,033,000 for the
second quarter ended June 30, 1997 from  $38,529,000 in the 1996 second quarter,
and  increased  28% to  $99,226,000  for the  first  six  months  of  1997  from
$77,447,000  for the 1996 six month  period.  Revenue  improvements  in the 1997
periods as compared to the 1996 periods were primarily attributable to growth in
the property/casualty  segment,  additional medical stop loss business resulting
from the  acquisition  of  Global  Excess  Re in  January  1997,  and  increased
production of provider excess  coverage.  Increases in net investment  income in
the 1997 periods result from higher levels of invested assets.

Consolidated  net  income  increased  4% to  $3,748,000  for the second
quarter  of  1997  from  $3,585,000  in the  second  quarter  of  1996,  and was
$7,408,000  for the first six months of 1997 as  compared to  $7,393,000  in the
1996 six month period.  Year to date 1997 results  include a decline in realized
gains to $255,000  from $726,000 in the 1996 first half.  Realized  gains in the
1996 periods were the result of two  transactions  in the first quarter of 1996.
Net income for the 1997  periods as compared to the 1996  periods  reflects  the
changes in  revenues  noted  above,  an increase  in medical  lines  claims cost
experience,  and  increases in income tax expenses as prior tax benefits were no
longer available. General and administrative expenses remained at 9% of revenues
in all periods  presented as the Company continued its focus on productivity and
expense control.

Income  taxes as a  percentage  of pre-tax  income  fluctuate  depending  on the
proportion of tax exempt investment  income to total pre-tax income,  the effect
of available tax benefits,  and the  proportion of total income subject to state
income taxes.

Insurance and reinsurance  companies  establish reserves for losses incurred but
not yet paid in order to match such losses with the related premiums earned. The
process of  establishing  loss reserves is subject to  uncertainties  that are a
normal,  recurring  aspect of the insurance  business  which requires the use of
informed  judgments and  estimates.  Loss and loss  adjustment  expense  reserve
development  is reviewed on a regular basis,  incorporating  analysis of current
trends,  market  changes  in the  Company's  business  segments  and  historical
experience  to  analyze  the  Company's  actuarial  assumptions.  As  additional
experience and other data becomes available,  the Company's  actuarial estimates
may be revised. Such revisions may impact earnings.  Policy acquisition expenses
vary on the basis of market conditions and mix of business.

                                       7

<PAGE>


The  statutory  combined  ratio  is the  traditional  indicator  of the
potential  underwriting   profitability  of  an  insurance  company's  business.
Statutory  combined  ratios are presented in  conformity  with rating agency and
industry   association   presentations   which  include  insurance  company  net
management  fee revenues in  calculating  such ratios.  The Company's  statutory
combined ratios were 99.2 and 97.8 for the six month periods ended June 30, 1997
and 1996, respectively.

Business Segments
-----------------

The Company conducts business in two segments:

Medical lines which includes  medical  stop-loss and provider  excess  coverages
underwritten by the Company's  subsidiary,  USBenefits Insurance Services,  Inc.
("USBenefits") on behalf of The Continental  Insurance Company  ("Continental"),
one of the  CNA  Insurance  Companies,  as well  as  reinsurance  of 50% of such
business  by the  Company's  USF RE  INSURANCE  COMPANY  ("USF RE")  subsidiary.
USBenefits is the managing  general  underwriter and marketing  organization for
medical lines coverages issued by Continental.  Medical stop-loss  coverage is a
form of insurance  that  protects  employers  that  self-insure  their  employee
healthcare  plans  by  limiting  their  exposure  from  the  risk  of  loss to a
pre-established  amount.  Provider  excess  coverage  limits the financial risks
healthcare  providers  face from medical plans that prepay the  providers  fixed
sums per plan  participant  (capitated  fees) or  provide  specified  rates  for
services.  USBenefits also markets other employee  benefits  related products on
behalf of several national life insurance companies.  Medical lines products are
marketed through a network of unaffiliated third party administrators, insurance
agents,  brokers and  consultants  ("Producers").  Producers have  non-exclusive
arrangements  with  USBenefits  that enable them to submit requests for coverage
quotations.

Property/Casualty  reinsurance and insurance underwriting is conducted by USF RE
and  its  wholly-owned  subsidiary,   USF  Insurance  Company  ("USFIC").  These
subsidiaries  both  carry  an A  (Excellent)  rating  from  A.M.  Best  Company.
Insurance companies purchase reinsurance in order to control and manage the risk
they  accept  when  they  issue  policies.  USF RE  assumes,  primarily  through
reinsurance intermediaries, facultative and treaty reinsurance from unaffiliated
insurance  companies.  Facultative is reinsurance of an individual  risk;  while
reinsurance  treaties  cover  risks  written or assumed by another  insurer in a
particular  class or classes  of  business.  USF RE  concentrates  its  casualty
writings in general liability, commercial auto liability and products liability.
It also  provides  a broad  range  of  coverages  for  most  types  of  property
exposures. USFIC writes surplus lines insurance on commercial  property/casualty
risks which are marketed through independent excess and surplus lines brokers.

                                       8

<PAGE>

The tables set forth below present  pre-tax  operating  information  by business
segment  and  holding  company  operations  (including  realized  gains) for the
quarters and six month periods ended June 30, 1997 and 1996, respectively.

<TABLE>

Medical lines
-------------
<CAPTION>
(Dollars in Thousands)

                                                    Quarter Ended                   Six Months Ended
                                                       June 30                          June 30
                                                       -------                          -------

                                              1997      1996      %Change        1997       1996    %Change
                                              ----      ----      -------        ----       ----    -------
       <S>                                 <C>       <C>            <C>      <C>         <C>           <C>
       Revenues:
           Premiums earned                 $ 25,538  $ 19,886       28%      $  50,570   $ 40,207      26%
                                                                            
           Commissions and fees               8,140     6,305       29%         16,182     12,894      26%
                                                      
           Investment income                    886       848        4%          1,751      1,597      10%
                                            -------   -------                ---------   --------
           Total revenues                    34,564    27,039       28%         68,503     54,698      25%
                                          ---------  --------                ---------   --------

       Expenses:
           Losses and loss adjustment        18,224    13,557       34%         36,110     27,395      32%
           Policy acquisition                 8,963     6,863       31%         17,569     13,719      28%
           General and  administrative        3,254     2,312       41%          6,593      4,784      38%
                                          ---------   -------                ---------   --------
           Total expenses                    30,441    22,732       34%         60,272     45,898      31%
                                          ---------  ---------               ---------   --------
       Income before income taxes          $  4,123   $ 4,307       (4)%     $   8,231   $  8,800      (6)%
                                           ========  ========                =========   ========

</TABLE>

Increases  in revenues  for the 1997  periods are due to growth in the  provider
excess line and  additional  medical stop loss business from the  acquisition of
Global Excess Re in January 1997. As a result,  medical lines segment production
increased  in the 1997  periods over the 1996  periods,  generating  the changes
noted above in premiums earned and commissions and fees revenues.

Loss and loss adjustment  expenses in the 1997 periods reflect  increases in the
cost of healthcare  which are not mitigated by increases in premium rates due to
ongoing  competitive  industry  conditions,  and an  increase  in the  Company's
medical stop-loss claims cost experience.  Policy acquisition  expenses vary due
to the level of production activity, mix of business and market conditions.

Increases in general and  administrative  expenses in the 1997 periods primarily
result from expenses  related to the  operations of the January  acquisition  of
Global Excess Re.


                                       9
<PAGE>



<TABLE>
Property/Casualty
-----------------
<CAPTION>
(Dollars in Thousands)

                                                   Quarter Ended                    Six Months Ended
                                                      June 30                            June 30
                                                      -------                            -------

                                           1997       1996       % Change         1997      1996      % Change
                                           ----       ----       --------         ----      ----      --------
       <S>                               <C>         <C>            <C>        <C>       <C>             <C>
       Revenues:
           Premiums earned               $ 12,565    $ 9,821        28%        $ 26,816  $ 18,652        44%
           Investment income                1,812      1,665         9%           3,626     3,339         9%
                                         --------    -------                   --------  --------
           Total revenues                  14,377     11,486        25%          30,442    21,991        38%
                                         --------    -------                   --------  --------

       Expenses:
           Losses and loss adjustment       9,302      7,295        28%          19,412    14,299        36%
           Policy acquisition               2,120      1,955         8%           5,423     3,973        36%
           General and administrative         913        872         5%           1,811     1,722         5%
                                          -------    -------                   --------  --------
           Total expenses                  12,335     10,122        22%          26,646    19,994        33%
                                          -------    -------                   --------  --------
       Income before income taxes         $ 2,042    $ 1,364        50%        $  3,796  $  1,997        90%
                                          =======    =======                   ========  ========

</TABLE>


The increases in premiums earned during the 1997 periods as compared to the 1996
periods primarily resulted from growth in the treaty reinsurance line.  Treaties
initiated  in 1996 and the  first  quarter  of 1997  favorably  impacted  second
quarter 1997 results.  The  magnitude of the impact on a comparative  basis will
decrease over the balance of the year as the business comes up for renewal.
Moderate growth of property/casualty  facultative operations also contributed to
1997 results.


Changes in losses and loss adjustment  expenses between periods reflect improved
loss experience in 1997. The increase in policy acquisition expenses in the 1997
periods  as  compared  to  1996  results  from  the  continued   growth  of  the
property/casualty business lines and changes in the mix of business.


                                       10

<PAGE>


<TABLE>
Holding Company
---------------
<CAPTION>
(Dollars in Thousands)
                                                    Quarter Ended                    Six Months Ended
                                                       June 30                            June 30
                                                       -------                            -------

                                              1997       1996     % Change       1997       1996       %Change
                                              ----       ----     --------       ----       ----       -------
       <S>                                   <C>        <C>        <C>         <C>          <C>          <C>
       Revenues:
           Investment income                 $ 14       $ 13         8%        $   26       $ 32         (19)%
           Realized gains                      78         (9)        --           255        726         (65)%
                                             ----       -----                  ------       ----
           Total revenues                      92          4         --           281        758         (63)%
                                             ----       -----                  ------       ----

       Expenses:
           General and administrative         280        195        44%           497        418          19%
           Interest                           614        699       (12)%        1,228      1,379         (11)%
                                             ----       ----                   ------     ------
           Total expenses                     894        894        --          1,725      1,797          (4)%
                                             ----       ----                  -------    -------
       Loss before income taxes            $ (802)    $ (890)      (10)%      $(1,444)   $(1,039)         39%
                                           =======    =======                 ========   ========
</TABLE>

Increases  in general and  administrative  expenses  result from higher
infrastructure  costs in the 1997 periods to support the growth of the Company's
business  lines.  Declines in interest  expenses in the 1997  periods are due to
quarterly reductions in the outstanding balance of bank debt, principal payments
on which  commenced  March  31,1997,  and changes in the variable  interest rate
charged on the outstanding balance.

Inflation
---------

Inflation can negatively impact insurance and reinsurance  operations by causing
higher claims  settlements  than may have originally  been estimated,  while not
necessarily  allowing an immediate  increase in premiums to a level necessary to
maintain  profit  margins.  Historically,  the  Company  has  made  no  explicit
provisions for inflation,  but trends are considered  when setting  underwriting
terms and claim  reserves.  Such reserves are subjected to a continual  internal
and external  review process to assess their adequacy and are adjusted as deemed
appropriate.  Overall economic trends also affect interest rates,  which in turn
affect  investment  income  and the  market  value of the  Company's  investment
portfolio.

Liquidity and Capital Resources
-------------------------------

The Company  utilizes cash from operations and maturing  investments to meet its
insurance  obligations  to  policyholders  and  claimants,  as  well  as to meet
operating  costs.  Primary  sources  of cash  from  operations  include  premium
collections,  investment  income and commissions and fees. The principal uses of
cash from operations are for premium payments to insurance  companies,  payments
of claims under USF RE's and USFIC's reinsurance and insurance  contracts,  debt
reduction,  and  operating  expenses  such as salaries,  commissions,  taxes and
general  overhead.  The Credit  Agreement  with the  Company's  lender  contains
certain covenants,  restrictions and dividend payment limitations with which the
Company was in compliance at June 30, 1997.


                                       11
<PAGE>



The Company  anticipates that it will continue to generate  sufficient cash flow
from  operations to cover its short-term  (1-18 months) and long-term (18 months
to 3 years) liquidity needs.  While the Company currently has no immediate plans
for significant capital outlays,  from time to time it contemplates  acquisition
opportunities that complement its business operations.

The  Company  currently  invests  primarily  in the  highest  grades  of  bonds,
equities,  certificates of deposit and short-term instruments. At June 30, 1997,
99% of the fixed income portfolio was in securities rated A or better.  All such
securities are carried at quoted market values at the latest balance sheet date.
The Company does not invest in real estate, derivatives or high yield bonds.

Forward Looking Statements
--------------------------

Some of the statements included within  Management's  Discussion and Analysis of
Financial  Condition and Results of Operations  and the  Consolidated  Financial
Statements and related Notes may be considered to be forward looking  statements
(as that term is  defined in the  Private  Securities  Litigation  Reform Act of
1995),  and which are subject to certain  risks and  uncertainties.  Among those
factors  which could cause the actual  results to differ  materially  from those
suggested by such statements are:  catastrophe losses in the Company's insurance
lines or a  material  aggregation  of  losses;  changes  in federal or state law
affecting  an  employer's  ability  to  self-insure;  availability  of  adequate
retrocessional  insurance  coverage  at  appropriate  prices;  a downturn in the
general economy;  the effects of competitive market pressures within the medical
lines or  property/casualty  marketplaces;  the  effect of changes  required  by
generally accepted accounting practices or statutory accounting  practices;  and
other risks which are described from time to time in the Company's  filings with
the Securities and Exchange Commission.

                                       12
<PAGE>



                            PART II OTHER INFORMATION

Item 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

(a)    The  Company's  1997  Annual  Meeting  of  Stockholders   ("Annual
Meeting")  was held on May 14,  1997 at the  Company's  offices  in Costa  Mesa,
California.  A total of  5,633,555  shares  were voted at the Annual  Meeting by
proxy,  representing  94.52% of the 5,960,148  shares of the Company's  $.01 par
value common stock issued,  outstanding and eligible to vote on the record date,
March 21, 1997.

(b)    The Company's board  currently  consists of seven  directors,  each
serving for three years,  who are divided into three classes.  Two directors are
elected at two Annual Meetings and three directors are elected at a third Annual
Meeting. At this 1997 Annual Meeting, the Company's  stockholders elected two of
the Company's  seven  directors for a term of three years expiring at the Annual
Meeting  of  Stockholders  in the  year  2000.  Management  nominated  long-term
directors  John F.  Kooken  and L.  Steven  Medgyesy,  and no  individuals  were
nominated in opposition to management's slate of directors.  Set forth below are
the results of the voting for the director nominees as reported by the Inspector
of Elections for the Company's Annual Meeting. There were no broker non-votes on
this proposal.

Name                                For                          Withhold
----                                ---                          --------
John F. Kooken                      5,590,157                    43,398
L.  Steven Medgyesy                 5,593,157                    40,398



The directors who are continuing in office are David L. Cargile, Bernard H. 
Ross, Kenneth C. Tyler, Charles L. Schultz, and Howard S. Singer.

(c)    The  Company's  stockholders  were  asked to  consider  five  other
matters as noted below.  The affirmative vote of a majority of the shares of the
Company's  common stock present at the Annual  Meeting in person or by proxy and
entitled to vote was required  for adoption of each such matter.  The results of
the vote on each of these  proposals  as reported by the  Inspector of Elections
are set forth below.

         (1) Approval of an amendment to the Company's  Restated  Certificate of
         Incorporation   to  change  the  Company's   name  from  US  Facilities
         Corporation to The Centris Group, Inc.

         For              Against           Abstain          Broker Non-Votes
         ---              -------           -------          ----------------
         5,584,769        32,929            15,857           0
  

       
                                       13
<PAGE>


         (2) Approval of an amendment to the Company's  Restated  Certificate of
         Incorporation  to increase  the number of shares of  authorized  common
         stock from 20,000,000 to 40,000,000.

         For              Against           Abstain          Broker Non-Votes
         ---              -------           -------          ----------------
         3,707,705        1,918,712         7,138            0


         (3) Approval of the adoption of the Company's 1997 Long-Term Incentive-
         Performance Unit plan.

         For               Against          Abstain          Broker Non-Votes
         ---               -------          -------          ----------------
         4,671,105         897,244          16,431           48,775


         (4) Approval of amendments to the Company's 1988 and 1991 Employee
         Stock Option Plans.

         For               Against          Abstain          Broker Non-Votes
         ---               -------          -------          ----------------
         3,097,255         1,392,540        15,219           1,128,541


         (5)  Ratification  of the  selection  by the Board of Directors of KPMG
         Peat  Marwick  LLP to continue  to serve as the  Company's  independent
         auditors for the fiscal year ending December 31, 1997.

         For               Against          Abstain          Broker Non-Votes
         ---               -------          -------          ----------------
         5,339,368         287,343          6,884            0



Item 6.  EXHIBITS and REPORTS ON FORM 8-K.

     (a) The  following  is a list of  exhibits  required to be filed as part of
         this Form 10-Q by Item 601 of Regulation S-K:

          3.1, 4.1   Restated  Certificate  of  Incorporation,  as amended,  as
                     presently in effect.  Filed  as  Exhibits  3.1  and  3.1.1
                     to the  Company's Form S-1 Registration Statement declared
                     effective by the Securities and Exchange Commission  on
                     October 31, 1986 (the "Registration Statement"), and
                     incorporated herein by this reference; as Exhibit 3 to the
                     Company's Current Report on Form 8-K dated May 24, 1990,
                     and incorporated herein by this reference; and as Exhibit
                     3(i) to the Company's Current Report on Form 8-K dated
                     May 14, 1997, and incorporated herein by this reference.

                                       14
<PAGE>


          3.2, 4.2   Bylaws of the Company, as amended, as presently in effect.
                     Filed under the Company's former name as  Exhibit  4.2 to
                     the  Company's Quarterly  Report on Form 10-Q for the
                     quarter ended June  30, 1994, and incorporated  herein
                     by this reference.

               4.3*  Common Stock  Certificate of The Centris Group,  Inc.
                     (reflecting new corporate name and new CUSIP number).

               4.4   Rights Agreement. Filed as Exhibit 2 to the Company's
                     Current Report on Form 8-K dated May 24, 1990, and
                     incorporated herein by this reference.

               4.5   First Amendment to Rights Agreement.  Filed as Exhibit 1 to
                     the Company's Current Report on Form 8-K dated January 16,
                     1992, and incorporated herein by this reference.

               4.6   Second  Amendment  to Rights  Agreement.  Filed as Exhibit
                     10.1 to the Company's  Current  Report on Form 8-K dated
                     April 29,  1994,  and  incorporated herein by this
                     reference.

               4.7   Third  Amendment to Rights Agreement.  Filed as Exhibit 4
                     to the Company's Current Report on Form 8-K dated
                     September 28, 1995, and incorporated herein by this
                     reference.

               11*   The Centris Group, Inc. and Subsidiaries Computation of
                     Earnings Per Share.

               15*   Independent Auditors' review report regarding unaudited
                     interim financial information.

               27*   Financial Data Schedules


(b)    During  the  second  quarter  of  1997,  the  Company  filed  with the
Securities  and Exchange  Commission a Current  Report on Form 8-K dated May 14,
1997, reporting that at the Company's Annual Meeting of Stockholders held on May
14, 1997,  stockholder  approval was  obtained to amend the  Company's  Restated
Certificate  of  Incorporation  to change the Company's  name from US Facilities
Corporation to The Centris Group, Inc., and to increase the number of authorized
common stock from 20,000,000 to 40,000,000  shares. The Certificate of Amendment
to the Restated Certificate of Incorporation was filed on May 14, 1997, with the
Secretary of State of Delaware and became effective on that date.

*   Describes exhibits filed with this Quarterly Report on Form 10-Q.


                                       15
<PAGE>



                                   SIGNATURES


Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.

The Centris Group, Inc.



Date:  August 7, 1996                   By: /S/ DAVID L. CARGILE
                                            --------------------
                                             DAVID L. CARGILE
                                             Chairman of the Board, President
                                             and Chief Executive Officer



Date:  August 7, 1996                   By: /S/ CHARLES M. CAPORALE
                                             ----------------------
                                             CHARLES M. CAPORALE
                                             Senior Vice President, Chief
                                             Financial Officer and Treasurer
                                             (Principal Financial and Accounting
                                             Officer)



                                       16
<PAGE>